New Zealand markets closed

Olympus Corporation (OCPNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.41-0.04 (-0.21%)
At close: 03:59PM EDT

Olympus Corporation

Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo 163-0914
Japan
81 3 3340 2111
https://www.olympus-global.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees31,557

Key executives

NameTitlePayExercisedYear born
Mr. Yasuo TakeuchiPres, CEO, Representative Exec. Officer & Director843.13kN/A1957
Mr. Stefan KaufmannExec. Officer, Chief Admin. Officer, Chief Strategy Officer, ESG Officer & Director1.44MN/A1968
Mr. Chikashi TakedaExec. Officer & CFON/AN/A1962
Mr. Nacho AbiaCOO & Exec. OfficerN/AN/A1968
Andre RoganExec. Officer & CTON/AN/AN/A
Stephen KneeboneCorp. Officer & Chief Information OfficerN/AN/AN/A
Takaaki SakuraiVP of Investor RelationsN/AN/AN/A
Ms. Donna MillerHead of HQ Legal and Global Gen. CounselN/AN/AN/A
Shigeto OhtsukiCorp. Officer & HR HeadN/AN/AN/A
Tetsuo KobayashiExec. Officer and Chief Manufacturing & Supply OfficerN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Corporate governance

Olympus Corporation’s ISS governance QualityScore as of 1 September 2022 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 4; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.